Group One Trading’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-34,258
Closed -$512K 8365
2022
Q4
$512K Buy
+34,258
New +$474K ﹤0.01% 3022
2022
Q3
Sell
-7,706
Closed -$59.2K 8718
2022
Q2
$51K Sell
7,706
-22,988
-75% -$111K ﹤0.01% 5543
2022
Q1
$172K Sell
30,694
-30,815
-50% -$127K ﹤0.01% 4963
2021
Q4
$288K Buy
61,509
+22,103
+56% +$137K ﹤0.01% 4707
2021
Q3
$244K Sell
39,406
-9,809
-20% -$58.7K ﹤0.01% 4965
2021
Q2
$324K Sell
49,215
-2,036
-4% -$14K ﹤0.01% 4708
2021
Q1
$375K Buy
+51,251
New +$442K ﹤0.01% 4378
2018
Q3
Sell
-25,048
Closed -$644K 5865
2018
Q2
$566K Buy
25,048
+17,135
+217% +$406K ﹤0.01% 2197
2018
Q1
$229K Buy
+7,913
New +$232K ﹤0.01% 2686
2015
Q4
Sell
-3,270
Closed -$40K 5313
2015
Q3
$40K Buy
3,270
+490
+18% +$7.08K ﹤0.01% 3671
2015
Q2
$48K Buy
2,780
+2,013
+262% +$36.2K ﹤0.01% 3563
2015
Q1
$11K Sell
767
-926
-55% -$10.1K ﹤0.01% 4122
2014
Q4
$14K Sell
1,693
-1,134
-40% -$10.4K ﹤0.01% 4120
2014
Q3
$31K Sell
2,827
-5,478
-66% -$69.6K ﹤0.01% 3868
2014
Q2
$152K Buy
8,305
+2,941
+55% +$38.3K ﹤0.01% 2630
2014
Q1
$80K Sell
5,364
-8,165
-60% -$147K ﹤0.01% 3263
2013
Q4
$249K Buy
13,529
+5,361
+66% +$107K ﹤0.01% 2235
2013
Q3
$169K Sell
8,168
-3,398
-29% -$77.8K ﹤0.01% 2530
2013
Q2
$289K Buy
+11,566
New +$494K 0.01% 1827

Group One Trading's AVEO Position: Q1 2023 in Review

Group One Trading sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 34,258 shares — an estimated $512K sold.

Group One Trading first reported a position in AVEO in Q2 2013 and held it in 19 quarters. The position peaked at $566K in Q2 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Group One Trading reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 34,258 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $512K.
  • Group One Trading first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
  • Group One Trading's AVEO Pharmaceuticals, Inc. position peaked at $566K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.